Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SAU:4013's EV-to-EBITDA is ranked worse than 80.89% of 518
companies
in the Healthcare Providers & Services industry
Industry Median: 10.43
vs SAU:4013: 23.79
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dr Sulaiman Al Habib Medical Services Group's PE Ratio (TTM) for today is calculated as:
Dr Sulaiman Al Habib Medical Services Group's share price for today is ﷼232.70.
Dr Sulaiman Al Habib Medical Services Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼6.910.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group EV-to-EBITDA Chart
Dr Sulaiman Al Habib Medical Services Group Annual Data
SAU:4013 vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group EV-to-EBITDA vs Healthcare Providers & Services Industry
Dr Sulaiman Al Habib Medical Services Group's current Enterprise Value is ﷼89,375 Mil.
Dr Sulaiman Al Habib Medical Services Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼3,756 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a EV-to-EBITDA of 23.80 as of Sep. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Sulaiman Al Habib Medical Services Group. This is 30% below median its historical median of 34.21. Over the past decade, Dr Sulaiman Al Habib Medical Services Group's EV-to-EBITDA has ranged from 17.37 to 47.79. According to the industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #419 out of 518 companies in the Healthcare Providers & Services industry, placing it in the top 80.9%.
Is Dr Sulaiman Al Habib Medical Services Group's EV-to-EBITDA too high?
Dr Sulaiman Al Habib Medical Services Group's current EV-to-EBITDA of 23.80 is 30% below median its 10-year median of 34.21. Over the past 10 years, this metric has ranged from a low of 17.37 to a high of 47.79. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.43. Dr Sulaiman Al Habib Medical Services Group's value of 23.80 is 128.2% above this industry median. Based on the distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #419 out of 518 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #419 out of 518 companies for EV-to-EBITDA. This places Dr Sulaiman Al Habib Medical Services Group in the lower half of its industry. The industry median EV-to-EBITDA is 10.43. Dr Sulaiman Al Habib Medical Services Group's value of 23.80 is 128.2% above this benchmark. Historically, Dr Sulaiman Al Habib Medical Services Group's own EV-to-EBITDA has ranged from 17.37 to 47.79 over the past decade. While the company's 10-year median is 34.21 vs. the industry median of 10.43, Dr Sulaiman Al Habib Medical Services Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.43, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current EV-to-EBITDA of 23.80 is 128.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Sulaiman Al Habib Medical Services Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current EV-to-EBITDA is 23.80, which is 30% below median its own 10-year median of 34.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼380.38, compared to a current price of ﷼232.70 — trading 38.8% below its estimated fair value. The current EV-to-EBITDA is 23.80, which is 30% below median its 10-year median of 34.21 and 128.2% above the Healthcare Providers & Services industry median of 10.43. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current EV-to-EBITDA is 23.80 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼232.70 is trading 38.8% below its estimated GF Value™ of ﷼380.38.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
EV-to-EBITDA: 23.80 (30% below median its 10-year median of 34.21)
GF Value™: ﷼380.38 vs. price of ﷼232.70 (38.8% below fair value)
Industry Position: 128.2% above the Healthcare Providers & Services median (#419 of 518)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
96GF Score
Get the complete analysis for SAU:4013
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
